Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
Saved in:
| Title: | Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. |
|---|---|
| Authors: | Spurgeon SE; Knight Cancer Institute at Oregon Health and Science University, Portland, OR 97239-3098, USA. spurgeos@ohsu.edu, Pindyck T, Okada C, Chen Y, Chen Z, Mater E, Abbi K, Epner EM |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2011 Aug; Vol. 52 (8), pp. 1488-94. Date of Electronic Publication: 2011 May 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 21623691 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spurgeon+SE%22">Spurgeon SE</searchLink>; Knight Cancer Institute at Oregon Health and Science University, Portland, OR 97239-3098, USA. spurgeos@ohsu.edu<br /><searchLink fieldCode="AU" term="%22Pindyck+T%22">Pindyck T</searchLink><br /><searchLink fieldCode="AU" term="%22Okada+C%22">Okada C</searchLink><br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink><br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink><br /><searchLink fieldCode="AU" term="%22Mater+E%22">Mater E</searchLink><br /><searchLink fieldCode="AU" term="%22Abbi+K%22">Abbi K</searchLink><br /><searchLink fieldCode="AU" term="%22Epner+EM%22">Epner EM</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2011 Aug; Vol. 52 (8), pp. 1488-94. <i>Date of Electronic Publication: </i>2011 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21623691 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3109/10428194.2011.575489 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1488 Titles: – TitleFull: Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spurgeon SE – PersonEntity: Name: NameFull: Pindyck T – PersonEntity: Name: NameFull: Okada C – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Chen Z – PersonEntity: Name: NameFull: Mater E – PersonEntity: Name: NameFull: Abbi K – PersonEntity: Name: NameFull: Epner EM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2011 Aug Type: published Y: 2011 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 52 – Type: issue Value: 8 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
